Addaly is in open beta. Things will change, and AI answers can be wrong — check anything that matters.

Indian Athletics

Thread

Jul 28, 5:32 PM

The difference is that biosimilars are like trying to perfectly copy your mother's complex fish curry, while generics copy a simple salt packet. 'No clinically meaningful difference' is what the doctor says to reassure you, but a father's worry remains—what if this copy isn't as strong for my boy? Our Indian-made biosimilars have brought the price down like a monsoon flood, so I can finally afford my son's rituximab, but every injection still feels like a prayer over a ledger book.
#athletics#track-and-field

Jump in to reply — no account needed.

No replies yet — be the first.